Position in REGN
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$402,183
-$218,246 QoQ
Shares Held
645
-19.7% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#864
of 1,322 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Moors & Cabot, Inc. holds $4,203,874 across 8 Biotechnology names. REGN ranks #4 (9.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,390 | $1,683,914 | |
| 2 | MRNA |
Moderna, Inc.
|
14,616 | $1,023,558 | |
| 3 | AXSM |
Axsome Therapeutics, Inc.
|
2,330 | $570,314 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
645 | $402,183 | |
| 5 | CRSP |
CRISPR Therapeutics AG
|
6,732 | $367,163 | |
| 6 | RXRX |
Recursion Pharmaceuticals, Inc.
|
19,550 | $71,748 | |
| 7 | IMRX |
Immuneering Corp
|
10,000 | $49,900 | |
| 8 | NGEN |
Nervgen Pharma Corp.
|
17,036 | $35,094 |
All Filings in REGN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $402,183 | 645 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $620,429 | 803 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $605,917 | 785 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $400,898 | 713 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $376,950 | 718 | Shares | Sole | 2025-08-06 | |
| 2025-03-31 | $535,924 | 845 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $559,179 | 785 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $837,838 | 797 | Shares | Sole | 2024-11-08 | |
| 2024-06-30 | $857,640 | 816 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $833,516 | 866 | Shares | Sole | 2024-05-08 | |
| 2023-12-31 | $738,641 | 841 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $690,463 | 839 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $571,957 | 796 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $652,405 | 794 | Shares | Sole | 2023-05-05 | |
| 2022-12-31 | $567,812 | 787 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $548,340 | 796 | Shares | Sole | 2022-11-08 | |
| 2022-06-30 | $508,962 | 861 | Shares | Sole | 2022-08-08 | |
| 2022-03-31 | $801,087 | 1,147 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $749,614 | 1,187 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $820,018 | 1,355 | Shares | Sole | 2021-12-08 | |
| 2021-06-30 | $704,877 | 1,262 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $590,951 | 1,249 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $390,835 | 809 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $436,628 | 780 | Shares | Sole | 2020-11-09 | |
| 2020-06-30 | $432,813 | 694 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $265,629 | 544 | Shares | Sole | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||